Paxlovid substantially reduced risk of hospitalization, death during Omicron wave

Nirmatrelvir–ritonavir (Paxlovid) significantly reduced the likelihood of hospitalization or death from COVID-19 in people at risk of severe illness, according to new research in Canadian Medical Association Journal (CMAJ).

source https://medicalxpress.com/news/2023-02-paxlovid-substantially-hospitalization-death-omicron.html